Intravenous thrombolysis prevents neurological deterioration in patients with acute pontine infarction

ObjectivesNeurological deterioration (ND) is common after acute isolated pontine infarction, and no evidence-based treatment is available to prevent this. We determined whether intravenous thrombolysis (IVT) with tissue plasminogen activator soon after pontine infarction prevents ND.MethodsWe retros...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhenxiao Chai, Weili Chen, Yichan Ye, Mengwan Song, Lingling Lin, Dongdong Lin, Xuerong Huang, Lifen Chi, Ruyue Huang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2025.1462372/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832591906017640448
author Zhenxiao Chai
Weili Chen
Yichan Ye
Mengwan Song
Lingling Lin
Dongdong Lin
Xuerong Huang
Lifen Chi
Ruyue Huang
author_facet Zhenxiao Chai
Weili Chen
Yichan Ye
Mengwan Song
Lingling Lin
Dongdong Lin
Xuerong Huang
Lifen Chi
Ruyue Huang
author_sort Zhenxiao Chai
collection DOAJ
description ObjectivesNeurological deterioration (ND) is common after acute isolated pontine infarction, and no evidence-based treatment is available to prevent this. We determined whether intravenous thrombolysis (IVT) with tissue plasminogen activator soon after pontine infarction prevents ND.MethodsWe retrospectively enrolled consecutive patients admitted to our hospital within 4.5 h after the onset of isolated pontine infarction identified using diffusion-weighted imaging. Patients were divided into the IVT and non-IVT groups. ND was defined as any ≥2-point increase in the National Institutes of Health Stroke Scale (NIHSS) score between the maximal and initial neurological deficits during hospitalization. Patients' clinical characteristics, laboratory findings, and outcomes were analyzed to determine the efficacy and safety of IVT.ResultsOf 211 study patients (median age, 67 years [interquartile range, 57–75 years]; 132 [62.6%] men), 74 received IVT; 137 patients did not receive IVT, but accepted other antithrombotic therapies, including antiplatelet or anticoagulant drugs. The NIHSS score on admission was higher in the IVT group than in the non-IVT group (7 vs. 4, P = 0.000), but that at discharge was similar in both groups (4 vs. 5, P = 0.975). ND occurred in 17 (23.0%) and 51 (37.2%) patients in the IVT and non-IVT groups, respectively (P = 0.044). Multiple logistic regression analysis identified IVT (odds ratio, 1.509; 95% confidence interval, 1.250–3.034) as an independent factor for preventing ND. The incidence of intracranial hemorrhagic transformation (P = 0.351) and major visceral organ hemorrhage (P = 0.122) was similar in both groups.ConclusionsIVT may prevent early ND after acute pontine infarction without increasing intracranial hemorrhagic transformation, possibly by decreasing the total thrombotic burden.
format Article
id doaj-art-550a934fe7354ed783a2d9101550f4ee
institution Kabale University
issn 1664-2295
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj-art-550a934fe7354ed783a2d9101550f4ee2025-01-22T05:19:36ZengFrontiers Media S.A.Frontiers in Neurology1664-22952025-01-011610.3389/fneur.2025.14623721462372Intravenous thrombolysis prevents neurological deterioration in patients with acute pontine infarctionZhenxiao ChaiWeili ChenYichan YeMengwan SongLingling LinDongdong LinXuerong HuangLifen ChiRuyue HuangObjectivesNeurological deterioration (ND) is common after acute isolated pontine infarction, and no evidence-based treatment is available to prevent this. We determined whether intravenous thrombolysis (IVT) with tissue plasminogen activator soon after pontine infarction prevents ND.MethodsWe retrospectively enrolled consecutive patients admitted to our hospital within 4.5 h after the onset of isolated pontine infarction identified using diffusion-weighted imaging. Patients were divided into the IVT and non-IVT groups. ND was defined as any ≥2-point increase in the National Institutes of Health Stroke Scale (NIHSS) score between the maximal and initial neurological deficits during hospitalization. Patients' clinical characteristics, laboratory findings, and outcomes were analyzed to determine the efficacy and safety of IVT.ResultsOf 211 study patients (median age, 67 years [interquartile range, 57–75 years]; 132 [62.6%] men), 74 received IVT; 137 patients did not receive IVT, but accepted other antithrombotic therapies, including antiplatelet or anticoagulant drugs. The NIHSS score on admission was higher in the IVT group than in the non-IVT group (7 vs. 4, P = 0.000), but that at discharge was similar in both groups (4 vs. 5, P = 0.975). ND occurred in 17 (23.0%) and 51 (37.2%) patients in the IVT and non-IVT groups, respectively (P = 0.044). Multiple logistic regression analysis identified IVT (odds ratio, 1.509; 95% confidence interval, 1.250–3.034) as an independent factor for preventing ND. The incidence of intracranial hemorrhagic transformation (P = 0.351) and major visceral organ hemorrhage (P = 0.122) was similar in both groups.ConclusionsIVT may prevent early ND after acute pontine infarction without increasing intracranial hemorrhagic transformation, possibly by decreasing the total thrombotic burden.https://www.frontiersin.org/articles/10.3389/fneur.2025.1462372/fullinfarctionponsintracranial hemorrhagic transformationintravenous thrombolysisneurological deterioration
spellingShingle Zhenxiao Chai
Weili Chen
Yichan Ye
Mengwan Song
Lingling Lin
Dongdong Lin
Xuerong Huang
Lifen Chi
Ruyue Huang
Intravenous thrombolysis prevents neurological deterioration in patients with acute pontine infarction
Frontiers in Neurology
infarction
pons
intracranial hemorrhagic transformation
intravenous thrombolysis
neurological deterioration
title Intravenous thrombolysis prevents neurological deterioration in patients with acute pontine infarction
title_full Intravenous thrombolysis prevents neurological deterioration in patients with acute pontine infarction
title_fullStr Intravenous thrombolysis prevents neurological deterioration in patients with acute pontine infarction
title_full_unstemmed Intravenous thrombolysis prevents neurological deterioration in patients with acute pontine infarction
title_short Intravenous thrombolysis prevents neurological deterioration in patients with acute pontine infarction
title_sort intravenous thrombolysis prevents neurological deterioration in patients with acute pontine infarction
topic infarction
pons
intracranial hemorrhagic transformation
intravenous thrombolysis
neurological deterioration
url https://www.frontiersin.org/articles/10.3389/fneur.2025.1462372/full
work_keys_str_mv AT zhenxiaochai intravenousthrombolysispreventsneurologicaldeteriorationinpatientswithacutepontineinfarction
AT weilichen intravenousthrombolysispreventsneurologicaldeteriorationinpatientswithacutepontineinfarction
AT yichanye intravenousthrombolysispreventsneurologicaldeteriorationinpatientswithacutepontineinfarction
AT mengwansong intravenousthrombolysispreventsneurologicaldeteriorationinpatientswithacutepontineinfarction
AT linglinglin intravenousthrombolysispreventsneurologicaldeteriorationinpatientswithacutepontineinfarction
AT dongdonglin intravenousthrombolysispreventsneurologicaldeteriorationinpatientswithacutepontineinfarction
AT xueronghuang intravenousthrombolysispreventsneurologicaldeteriorationinpatientswithacutepontineinfarction
AT lifenchi intravenousthrombolysispreventsneurologicaldeteriorationinpatientswithacutepontineinfarction
AT ruyuehuang intravenousthrombolysispreventsneurologicaldeteriorationinpatientswithacutepontineinfarction